Evaluation of the DELTA Revision acetabular cup in hip arthroplasty

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates the clinical and radiographic outcomes of 49 patients who have undergone total hip arthroplasty using the DELTA Revision acetabular cup. The study aims to reflect real-life clinical practices, allowing clinicians to choose their methods of implantation based on local guidelines and practices. Participants will be monitored to assess the effectiveness and safety of the DELTA Revision cup in treating hip osteoarthritis.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* male or female in whom a decision has already been made to perform a total hip arthroplasty with DELTA Revision acetabular cup as per indication for use. The decision to implant DELTA revision acetabular cup must be taken prior to, and independently from the decision to enroll the patient. This decision should be made in accorsance with routine clinical practice at the study site concerned.
* Age ≥ 18 years old
* All patients mist give written informed consent approved by the study site's Institutinal Review Board (IRB)/Ethical Committee (EC)
* Patient is able to comply with the protocol

Exclusion Criteria:

* Adult patients with any DELTA Revision acetabular cup contraindication for use as reported in the current local instruction for use.
* For female patiens, current pregnancy and/or lactation or planning a pregnancy

Where it's running

• Samodzielny Publiczny Szpital Kliniczny im. Prof. Adama Grucy CMKP
  Otwock, Poland Recruiting

Study contacts

• Principal investigator: Jerzy Bialecki — Samodzielny Publiczny Szpital Kliniczny im. Prof. Adama Grucy CMKP
• Study coordinator: Federica Azzimonti
• Email: federica.azzimonti@limacorporate.com
• Phone: +39 377 5450940

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Ceramic hip resurfacing vs total hip arthroplasty for hip OA

  This trial tests whether ceramic hip resurfacing helps people with hip OA walk farther each day than a modern total hip replacement.

  Recruiting Danderyd Hospital · Danderyd · NCT07839403

• Dexmedetomidine during hip replacement to modulate nerves and inflammation

  A randomized, placebo-controlled study tests whether intravenous dexmedetomidine given during spinal anesthesia with a PENG nerve block can help regulate the body's stress and inflammatory response and improve recovery after hip replacement.

  Recruiting Poznan University of Medical Sciences · Poznan · NCT07743853

• Preoperative Fasting to Shape the Gut with Hip Replacement

  This trial tests whether a 20-day preoperative fasting plan can lower inflammatory signals and broaden gut microbes in adults undergoing total hip arthroplasty.

  Recruiting Charite University, Berlin, Germany · Berlin, State of Berlin · NCT07651462

• Cryoneurolysis for Chronic Pain: 6- and 12-Month Outcomes in Routine Care

  This study tests whether cryoneurolysis, done as part of standard care for people with chronic pain, leads to meaningful improvements over 6 to 12 months.

  Recruiting Yale University · Old Saybrook, Connecticut · NCT07639060

• Spinal anesthesia with intrathecal morphine vs PENG block (with or without dexamethasone) for hip replacement

  In people aged 60 and older undergoing total hip arthroplasty, this study tests whether three anesthesia approaches provide better pain control and fewer side effects: spinal with intrathecal morphine, spinal with a PENG block, or spinal with a PENG block plus dexamethasone.

  Recruiting Poznan University of Medical Sciences · Poznan · NCT07584200

• Intravenous dexamethasone for better pain control after hip replacement with a PENG block

  This study tests whether giving dexamethasone through a vein, in 0, 4, or 8 mg doses, helps control pain after total hip arthroplasty when used with a PENG block.

  Recruiting Poznan University of Medical Sciences · Poznan · NCT07581470

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.